SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies
I think these headlines, possibly purposefully, overlook the possibility that vaccine antibodies eased acquisition of infection induced antibodies to the point of being subclinical events.That is, a vaccinated person could be exposed to a variant for which they are partially protected, not notice clinical symptoms, while the person's immune system still remembers the details of the variant.As an iterative process, this is akin to software updates (for a running immune system).So to say that variant A.30 isn't covered by the mRNA induced spike protein antibodies is a very different statement than to say it's able to evade an immune system primed by mRNA antibodies which then re-entered daily life and thereby was able to continuously adapt to variants.